Peptides: what physicians need to know
News, regulation and evidence on peptides in Barbados: what the law, the regulators and the studies say, with every fact linked to its source.
Regulation
Barbados Medical Products Act 2026: what the new authority changes
Barbados has a new medicines law. The Barbados Medical Products Act, 2026 creates an autonomous regulator, requires marketing authorisation for every medical product, bans off-label advertising and repeals the Therapeutic Substances Act. Here is what physicians in Barbados need to know before it starts.
Read article →
Market
Weight-loss drugs on the Barbados National Drug Formulary? The plan
Prime Minister Mia Mottley says weight-loss medication is a manifesto commitment for the Barbados National Drug Formulary. Here is what that would mean in Barbados: the evidence for semaglutide and tirzepatide, the WHO position, the cost problem and the open questions for physicians.
Read article →
Clinical practice
Childhood obesity in Barbados hits 42%: the fight over school food
Four in ten Barbadian children and teenagers are now overweight or obese, up from a third a decade earlier. Ministers, researchers and advocates in Barbados disagree on how hard to push the School Nutrition Policy, and what it means for physicians who will treat these children as adults.
Read article →